The company
Organon & Co.
OGN · NYSE
OGN stood above a rising 150-day average in 25 of the last 52 weekly readings, including each of the last 25 weeks. It is 9.6% above that average now. Pharmaceuticals: 35% of its 74 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 25 in a row
- Industry in uptrend
- 35% -4 in 4 wk
- Insider buys, 12 months
- $1.2M
- Insider sales, 12 months
- $1.1M
- Officials’ trades on record
- 7
- Institutions holding
- 580 (+21)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
7 disclosed lines: House 2, Senate 2, executive 3; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $1k–$15k | 5 Aug 2026filed 12 Aug 2026 |
| Kevin Hern House: U.S. House ClerkOK01 | soldjoint | $1k–$15k | 5 Aug 2026filed 10 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 4 Mar 2026filed 14 May 2026 |
| Gary C. Peters Senate: U.S. Senate eFDSenator | sold | $1k–$15k | 10 Jul 2025filed 24 Nov 2025 |
| John W. Hickenlooper Senate: U.S. Senate eFDSenator | sold | $1k–$15k | 28 Jun 2021filed 9 Jul 2021 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Juliana Papa DrinaneHead of Mfg & Supply | sold | 14,761at $13.57 | 5 Aug 2026filed 5 Aug 2026 |
| Lynette HolzbaurSVP and Corporate Controller | bought | 26,448.366at $13.35 | 6 May 2026filed 7 May 2026 |
| Lynette HolzbaurSVP and Corporate Controller | sold | 26,448.366at $13.35 | 6 May 2026filed 7 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 32,056,866$434.0M | +339,838+1.1% |
| Pentwater Capital Management LPnew · filed 14 Aug 2026 | 18,100,000$245.1M | +18,100,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 15,132,118$204.9M | -6,713,918−30.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 11,909,865$161.3M | +172,847+1.5% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 9,659,371$130.8M | -297,403−3.0% |
| KAHN BROTHERS GROUP INCunchanged · filed 14 Aug 2026 | 5,536,993$33.2M | 00.0% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 5,199,002$70.4M | +3,593,677+223.9% |
| UBS Group AGadded · filed 13 Aug 2026 | 4,856,529$65.8M | +1,384,950+39.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 4,815,610$65.2M | +56,273+1.2% |
| ALLIANCEBERNSTEIN L.P.added · filed 14 Aug 2026 | 4,754,671$28.5M | +4,034,159+559.9% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.